Liver-directed moderately hypo-fractionated radiotherapy combined with pembrolizumab and bevacizumab for advanced hepatocellular carcinoma: a retrospective observational study of 23 cases - Liang, Xuexia; Jiang, Yanhui; Yao, Wei; Deng, Yun; Yang, Shuai; Liu, Qiaodan (Translational Cancer Research; Vol 13, No 3 (March 31, 2024): Translational Cancer Research, 2024)